GGrantIndex
← Leaderboards

Patrick J Mc Grath

New York State Psychiatric Institute

$6,630,000
Attributed
$12,591,555
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200915
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$12,591,555 · 5

By mechanism

U01$8,942,332 · 1
R01$2,045,967 · 1
RC1$951,326 · 1
R10$651,653 · 1
M01$277 · 1

Top collaborators

Most similar at New York State Psychiatric Institute

Same institution · by research overlap

Others in their field

Top investigators on “Treatment Outcome

Research focus

Treatment OutcomeDisease RemissionMajor Depressive DisorderPharmaceutical PreparationsBrainResponseAdverse EventMental DepressionEtiologyClinical ManagementEscitalopramAntidepressive AgentsClinical AssessmentsBiosignatureExecutive FunctionElectroencephalographyBinding (Molecular Function)Data SetEmotionsBiocompatible MaterialsBupropionBiomarkerBaseChronic

Grant awards (19)

Biosignatures of Treatment Remission in Major Depression$457,863
U01 · FY2015 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,792,950
U01 · FY2013 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$141,638
U01 · FY2013 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,778,562
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$548,996
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$41,673
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$29,926
U01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,807,205
U01 · FY2011 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$614,421
U01 · FY2011 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,729,098
U01 · FY2010 · MH
Developing a PET biomarker to predict response in treatment-resistant depression$480,435
RC1 · FY2010 · MH · contact PI
Developing a PET biomarker to predict response in treatment-resistant depression$470,891
RC1 · FY2009 · MH · contact PI
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$454,039
R01 · FY2004 · AA
Continuation PET$277
M01 · FY2004 · RR
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$457,123
R01 · FY2003 · AA
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$564,711
R01 · FY2002 · AA
ALCOHOL USE DISORDER IN PATIENTS TREATED FOR DEPRESSION$570,094
R01 · FY2001 · AA
PREDICTION OF OUTCOME DURING FLUOXETINE$251,135
R10 · FY2001 · MH
PREDICTION OF OUTCOME DURING FLUOXETINE CONTINUATION$400,518
R10 · FY2000 · MH